Advertisement

Topics

RadioSurgery Partners Company Profile

07:21 EST 11th December 2018 | BioPortfolio


News Articles [263 Associated News Articles listed on BioPortfolio]

In melanoma, radiosurgery may combine well with immunotherapy, especially PD-1 inhibitors

(University of Colorado Anschutz Medical Campus) Of 38 melanoma patients treated with immunotherapy and radiosurgery between 2012 and 2017, median overall survival was not reached.

Stereotactic Radiosurgery May Not Raise Risk of Intracranial Malignancy

Patients who undergo stereotactic radiosurgery for benign indications do not appear to be at increased risk of malignant transformation, new findings show. Reuters Health Information

EU5 Radiosurgery Systems Market Outlook to 2025 [Report Updated: 01112018] Prices from USD $5096

EU5 Radiosurgery Systems Market Outlook to 2025SummaryGlobalData's new report, EU5 Radiosurgery Systems Market Outlook to 2025, provides key market data on the EU5 Radiosurgery Systems market. The rep...

EU5 Radiosurgery Systems Market Outlook to 2025 [Report Updated: 01112018] Prices from USD $5995

EU5 Radiosurgery Systems Market Outlook to 2025SummaryGlobalData's new report, EU5 Radiosurgery Systems Market Outlook to 2025, provides key market data on the EU5 Radiosurgery Systems market. The rep...

Spain Radiosurgery Systems Market Outlook to 2025 [Report Updated: 19102018] Prices from USD $4246

Spain Radiosurgery Systems Market Outlook to 2025SummaryGlobalData's new report, Spain Radiosurgery Systems Market Outlook to 2025, provides key market data on the Spain Radiosurgery Systems market. T...

Germany Radiosurgery Systems Market Outlook to 2025 [Report Updated: 19102018] Prices from USD $4246

Germany Radiosurgery Systems Market Outlook to 2025SummaryGlobalData's new report, Germany Radiosurgery Systems Market Outlook to 2025, provides key market data on the Germany Radiosurgery Systems mar...

Canada Radiosurgery Systems Market Outlook to 2025 [Report Updated: 19102018] Prices from USD $4995

Canada Radiosurgery Systems Market Outlook to 2025SummaryGlobalData's new report, Canada Radiosurgery Systems Market Outlook to 2025, provides key market data on the Canada Radiosurgery Systems market...

Mexico Radiosurgery Systems Market Outlook to 2025 [Report Updated: 19102018] Prices from USD $4995

Mexico Radiosurgery Systems Market Outlook to 2025SummaryGlobalData's new report, Mexico Radiosurgery Systems Market Outlook to 2025, provides key market data on the Mexico Radiosurgery Systems market...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [343 Associated PubMed Articles listed on BioPortfolio]

Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives.

Today, stereotactic radiosurgery is an effective therapy for a variety of intracranial pathology that were treated solely with open neurosurgery in the past. The technique was developed from the combi...

Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.

The purpose of this study was to retrospectively evaluate the new treatment paradigm of staged stereotactic radiosurgery (SRS) for the treatment of large brain metastases (BM) compared to the standard...

Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.

Brain metastases are common in metastatic melanoma and radiosurgery is often utilized for local control. Immune checkpoint inhibitors (CPIs) play a central role in contemporary melanoma management; ho...

Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.

The aim of this study was to evaluate the efficacy of stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (fSRT) as salvage therapy for recurrent high-grade glioma and to look a...

Management of residual brain arteriovenous-malformations after stereotactic radiosurgery.

To assess the outcome of residual bAVM after stereotactic radiosurgery.

Clinical Trials [518 Associated Clinical Trials listed on BioPortfolio]

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery after surgery may kill any tu...

Resection Bed Post-Surgical Stereotactic Radiosurgery (SRS)

The goal of this clinical research study is to learn if stereotactic radiosurgery can help to reduce the risk of a brain tumor returning after surgery. The safety of this treatment will al...

Stereotactic Radiosurgery (SRS) for Multiple CNS Mets

This study is designed to determine outcome for patients with 5 or more central nervous system (CNS) metastatic lesions treated with stereotactic radiosurgery (SRS).

Stereotactic Radiosurgery in Treating Patients With Brain Metastases

RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery before surgery may make the t...

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiosurgery may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. It is n...

Companies [940 Associated Companies listed on BioPortfolio]

Accuray

Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fel...

RadioSurgery Partners

Accuray Incorporated

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option ...

Alliance Oncology

Alliance Oncology partners with hospitals and radiation oncologists to set a new standard of care for cancer patients. This is achieved through the establishment of state-of-the-a...

Cromwell Hospital

The Cromwell Hospital in London provides healthcare facilities for UK and overseas patients. Major specialities include cancer treatment, liver disease and transplant, neurosurgery, spinal surgery, he...

More Information about "RadioSurgery Partners" on BioPortfolio

We have published hundreds of RadioSurgery Partners news stories on BioPortfolio along with dozens of RadioSurgery Partners Clinical Trials and PubMed Articles about RadioSurgery Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RadioSurgery Partners Companies in our database. You can also find out about relevant RadioSurgery Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record